Zdrowie i gospodarka · 01/10/1999

FDA Releases Draft Guidance on Reporting Changes to Approved NADA or ANADA Applications

The Food and Drug Administration (FDA) has released a draft guidance document outlining recommendations for holders of new animal drug applications (NADA's) and abbreviated new animal drug applications (ANADA's) on how to report changes to their applications in accordance with proposed amended regulations.